Skip to main content
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Inflammation. 2014 Oct;37(5):1401–1412. doi: 10.1007/s10753-014-9864-7

Fig. 2.

Fig. 2

Effects of L-4F and apoA-I on TNF-α-mediated production of IL-6 in whole human blood. L-4F or apoA-I (40 μg/ml) does not reduce plasma levels of IL-6 in the healthy whole human blood incubated with T-NF-α (10 ng/ml) for 6 h in vitro (n=4/group). #P<0.05 vs. control groups.